Guilherme R Carvalho M.d. Inc. | |
118 N Santa Fe St Ste A Hemet CA 92543-4441 | |
(951) 652-6891 | |
Not Available |
Full Name | Guilherme R Carvalho M.d. Inc. |
---|---|
Speciality | Internal Medicine |
Location | 118 N Santa Fe St, Hemet, California |
Authorized Official Name and Position | Chitra Carvalho (OFFICE MANAGER) |
Authorized Official Contact | 9516526891 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Guilherme R Carvalho M.d. Inc. 118 N Santa Fe St Ste A Hemet CA 92543-4441 Ph: () - | Guilherme R Carvalho M.d. Inc. 118 N Santa Fe St Ste A Hemet CA 92543-4441 Ph: (951) 652-6891 |
NPI Number | 1013288117 |
---|---|
Provider Enumeration Date | 01/20/2012 |
Last Update Date | 01/20/2012 |
Identifier | Type | State | Issuer |
---|---|---|---|
1013288117 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | A33335 (California) | Primary |
News Archive
Teens who talk to strangers online are more likely to become victims of online harassment than those who share their personal information on the Internet, according to a report in the February issue of Archives of Pediatrics & Adolescent Medicine.
Zeroing in on the early cell mutations that enable a cancer to grow is one of the best ways to find a personalized therapy to stop it. Scientists were able to use a statistical approach for the first time to map out the order in which these abnormalities form to analyze the pattern of DNA changes in advanced skin and ovarian tumors.
BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.
Transcept Pharmaceuticals, Inc. announced today plans to reduce operating expenses by eliminating approximately 45% of its workforce following notification from the U.S. Food and Drug Administration (FDA) that the resubmitted New Drug Application (NDA) for Intermezzo, the company's lead product candidate, cannot be approved in its present form.
The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
› Verified 9 days ago
Sreenivasa R. Nakka, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 949 Calhoun Pl, Ste A, Hemet, CA 92543 Phone: 951-929-1177 Fax: 951-765-9111 | |
Mdcare Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1278 E Latham Ave, Hemet, CA 92543 Phone: 951-537-9868 | |
David Perz, D.o. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2591 W Florida Ave, Hemet, CA 92545 Phone: 951-766-4329 Fax: 951-766-8056 | |
Tri-state Community Healthcare Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 540 N San Jacinto St Ste P, Hemet, CA 92543 Phone: 951-929-4000 | |
Sj Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 422 N San Jacinto St, Hemet, CA 92543 Phone: 951-566-6585 Fax: 888-696-2590 | |
Innercare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1023 E Florida Ave, Hemet, CA 92543 Phone: 951-599-8403 Fax: 951-766-0930 |